  See all
 |
Articles: Lung/Thoracic Oncology |
Prior Articles
Pulmonary neuroendocrine/carcinoid tumors
Cancer, 07/01/09
Cancer mortality in patients with schizophrenia
Cancer, 06/30/09 Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features
Molecular Carcinogenesis, 06/30/09 Tumour characteristics and therapeutic results after percutaneous radiofrequency ablation of secondary lung neoplasms
Clinical and Translational Oncology, 06/30/09 Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer
Journal of Thoracic Oncology, 06/29/09 Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: An exploratory analysis
Palliative & Supportive Care, 06/29/09 Outcomes of patients with stage III non-small cell lung cancer treated with chemotherapy and radiation with and without surgery
Cancer, 06/26/09 Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
Proceedings of the National Academy of Sciences of the United States of America, 06/26/09 The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: Implications for tumour coverage
Radiotherapy and Oncology, 06/26/09 4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis
Radiotherapy and Oncology, 06/26/09 Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC
Radiotherapy and Oncology, 06/26/09 Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical study
Radiotherapy and Oncology, 06/26/09 Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
Radiotherapy and Oncology, 06/26/09 High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL
Radiotherapy and Oncology, 06/26/09 Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer
Radiotherapy and Oncology, 06/26/09 Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses
Radiotherapy and Oncology, 06/26/09 Dose–volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy
Radiotherapy and Oncology, 06/26/09 Increased 18F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): A prospective pilot study
Radiotherapy and Oncology, 06/26/09 Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients
Radiotherapy and Oncology, 06/26/09 The importance of patient characteristics for the prediction of radiation-induced lung toxicity
Radiotherapy and Oncology, 06/26/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
